Search Result "Bifeprunox"
A Candidate Pathway Strategy for Integration of Pharmacogenomic Components of Variability in Antipsychotic Treatment Outcomes: A Focus on Aripiprazole
Journal: Current Pharmacogenomics
Volume: 3 Issue: 4 Year: 2005 Page: 305-317
Author(s): Christopher Reist, Lawrence J. Albers, Stephen R. Marder, Bryn Williams-Jones, Joseph C. Wu, Steven Mee, Kazutaka Shimoda, Toshiyuki Someya, Vural Ozdemir
D2 Receptor Partial Agonists: Treatment of CNS Disorders of Dopamine Function
Journal: Current Topics in Medicinal Chemistry
Volume: 8 Issue: 1 Year: 2008 Page: 1068-1088
Author(s): John H. Kehne, Terrance H. Andree, Julia N. Heinrich
Antipsychotic Medication: The Potential Role of 5-HT1A Receptor Agonism
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 5 Year: 2010 Page: 516-521
Author(s): Andrew C. McCreary, Caitlin A. Jones
Serotonin 5-HT1A Receptors and Antipsychotics - An Update in Light of New Concepts and Drugs
Journal: Current Pharmaceutical Design
Volume: 21 Issue: 26 Year: 2015 Page: 3725-3731
Author(s): Andrew C. McCreary,Adrian Newman-Tancredi
The Neuropharmacological Potential of Piperazine Derivatives: A Mini-Review
Journal: Mini-Reviews in Organic Chemistry
Volume: 19 Issue: 7 Year: 2022 Page: 798-810
Author(s): Mohammed M. Alshehri
Neurovascular Complications of Ovarian Hyperstimulation Syndrome (OHSS): From Pathophysiology to Recent Treatment Options
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 8 Issue: 2 Year: 2014 Page: 109-116
Author(s): Rocco S. Calabro,Giuseppe Gervasi,Antonino Leo,Rosaria De Luca,Tina Balletta,Carmela Casella,Onofrio Triolo,Placido Bramanti
Dual Ligands Targeting Dopamine D2 and Serotonin 5-HT1A Receptors as New Antipsychotical or Anti-Parkinsonian Agents
Journal: Current Medicinal Chemistry
Volume: 21 Issue: 4 Year: 2014 Page: 437-457
Author(s): Na Ye, Zilan Song, Ao Zhang
Conditioned Avoidance Response in the Development of New Antipsychotics
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 3 Year: 2010 Page: 358-370
Author(s): M-L. G. Wadenberg
Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, Present and Future
Journal: Current Topics in Medicinal Chemistry
Volume: 16 Issue: 2 Year: 2016 Page: 3385-3403
Author(s): Peng Li, Gretchen L. Snyder, Kimberly E. Vanover
Third Generation Antipsychotic Drugs: Partial Agonism or Receptor Functional Selectivity?
Journal: Current Pharmaceutical Design
Volume: 16 Issue: 5 Year: 2010 Page: 488-501
Author(s): Richard B. Mailman, Vishakantha Murthy